SCHEMBL9979537

SCHEMBL9979537

CCO/N=C(/C)c1ccc(-c2ccccc2NC(=O)c2cn(C)nc2C(F)(F)F)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.47
POLB P06746 1/20 0.47
ALDH1A1 P00352 4/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
NTRK1 P04629 1/20 0.41
STING1 Q86WV6 1/20 0.40
KDM4E B2RXH2 3/20 0.39
MAPT P10636 2/20 0.39
NPSR1 Q6W5P4 1/20 0.39
S1PR1 P21453 1/20 0.39
DGAT1 O75907 5/20 0.39
ABCB1 P08183 1/20 0.39
ABCG2 Q9UNQ0 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2D6 P10635 1/20 0.39
CYP2C9 P11712 1/20 0.39
HPGD P15428 1/20 0.39
CYP2C19 P33261 1/20 0.39
TDP1 Q9NUW8 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9979667 0.93 LMNA (0.43) LMNAPOLBALDH1A1L3MBTL1NTRK1
SCHEMBL9979726 0.91 LMNA (0.42) LMNAPOLBALDH1A1L3MBTL1NTRK1
SCHEMBL13215993 0.89 LMNA (0.41) LMNAPOLBALDH1A1L3MBTL1NTRK1
SCHEMBL9979590 0.89 LMNA (0.46) LMNAPOLBALDH1A1L3MBTL1NTRK1
SCHEMBL9979603 0.87 ATM (0.52) LMNAPOLBALDH1A1L3MBTL1KDM4E
SCHEMBL9979529 0.85 LMNA (0.45) LMNAPOLBALDH1A1L3MBTL1NTRK1
SCHEMBL14578046 0.83 LMNA (0.68) LMNAPOLBALDH1A1L3MBTL1NTRK1
SCHEMBL1085471 0.82 LMNA (0.57) LMNAPOLBALDH1A1L3MBTL1NTRK1
SCHEMBL14266795 0.82 LMNA (0.54) LMNAPOLBALDH1A1L3MBTL1NTRK1
SCHEMBL4100026 0.82 NTRK1 (0.56) LMNAPOLBALDH1A1NTRK1STING1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1305292-B1 BIPHENYL CARBOXAMIDES BAYER CROPSCIENCE AG (DE) 2012-06-20 EP disclosed
US-20100216849-A1 BIPHENYLCARBOXAMIDES DUNKEL RALF 2010-08-26 US disclosed
US-7728019-B2 Biphenylcarboxamides BAYER CROPSCIENCE AG (DE) 2010-06-01 US disclosed
US-20080085924-A1 Biphenylcaboxamides BAYER CROPSCINCE AG (DE) 2008-04-10 US disclosed
US-7176228-B2 Pyrazole biphenylcarboxamides BAYER CROPSCIENCE AG (DE) 2007-02-13 US disclosed
US-7176228-B2 Pyrazole biphenylcarboxamides BAYER CROPSCIENCE AG (DE) 2007-02-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080085924-A1 Biphenylcaboxamides AHR, Q6ZSR9, DDT LMNA 1108/4885POLB 1531/4885ALDH1A1 415/4885
US-20100216849-A1 BIPHENYLCARBOXAMIDES AHR, DDT, MRPL21 LMNA 765/4885POLB 1106/4885ALDH1A1 478/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.